NBIX Stock Ownership Activity

NEUROCRINE BIOSCIENCES INC 13F holders

No value investing guru has made any change to the NEUROCRINE BIOSCIENCES INC (NBIX) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying NBIX now?

According to the latest SEC filing(s) NEUROCRINE BIOSCIENCES INC (NBIX) has not been purchased by any super investor.

To see more about who is investing in NEUROCRINE BIOSCIENCES INC (NBIX), please go to the NBIX ownership page.

2025 Q1 (1 result)
V. D. Dodge, E. M. Cox
+101.28%
+1,994,564
+0.20%
0.39%
Current price: $141.87 28.27% Reported price*: $110.60
2024 Q4 (1 result)
V. D. Dodge, E. M. Cox
+181.23%
+1,269,148
+0.16%
0.24%
Current price: $141.87 3.93% Reported price*: $136.50
2024 Q2 (1 result)
V. D. Dodge, E. M. Cox
+0.74%
+5,140
+0.00%
0.09%
Current price: $141.87 3.05% Reported price*: $137.67
2023 Q4 (1 result)
V. D. Dodge, E. M. Cox
+388.41%
+552,818
+0.07%
0.09%
Current price: $141.87 7.67% Reported price*: $131.76
2023 Q3 (1 result)
V. D. Dodge, E. M. Cox
buy
+142,330
+0.02%
0.02%
Current price: $141.87 26.11% Reported price*: $112.50
5 of 5

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.